Table:
begin	end	state
1	6	cytoplasmic
7	28	transmembrane
29	49	non-cytoplasmic
50	69	transmembrane
70	80	cytoplasmic
81	98	transmembrane
99	103	non-cytoplasmic
104	127	transmembrane
128	140	cytoplasmic
141	161	transmembrane
162	180	non-cytoplasmic
181	200	transmembrane
201	260	cytoplasmic
261	284	transmembrane
285	298	non-cytoplasmic
299	320	transmembrane
321	326	cytoplasmic
327	347	transmembrane
348	363	non-cytoplasmic
364	389	transmembrane
390	400	cytoplasmic
401	419	transmembrane
420	423	non-cytoplasmic
424	449	transmembrane
450	466	cytoplasmic

Input:
>Ga0059261_1891
MNGESRANMGLIMAIVAVATIGGLLFGYDSGAVNGTQDGLKSAFALSEGGLGFTVGSLLI
GCFIGAFLAGRLADLIGRRNVMILTAVLFLIGALIQGFSHEQWIFVAARIAGGMAVGAAS
VLSPAYISEVAPANIRGRMTTIQQIMIISGLTAAFVVNYWLAKTAGASTNLFWGGYEAWR
WMYWMQAIPATVFLIALFFIPESPRYLVSKGRNAEATRVLTSLFGAGTATNKLTEIQASF
SDHRPTLRDILDPVKGGVRPIVWAGLLLAVFQQLVGINVIFYYGATLWQLAGFTENDALL
INIVSGFVSIAACFVTVALVDRIGRKPLLLIGSAGMAVALFAMVFAFSRGSLDAQGKLVL
SQQLGIIAVIAANLYVVFFNVSWGPVMWVMLGEMFPNQIRGSALAVCGFAQWFSNYLIAQ
SFPIMAAGLGLAVSYSFYAVCAVISFFLVSKFIHETKGVELEDMQG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server